Skip to main content
Explore URMC

Matthew D. McGraw, M.D.

Contact Information

Phone Numbers

Administrative: (585) 275-2464

Fax: (585) 275-8706

URMFGA member of the University of Rochester Medical Faculty Group

groupAn Accountable Health Partner

assignmentAccepting New Patients

Research Labs

Faculty Appointments

Patient Care Setting



Dr. McGraw's primary goal as a pediatric pulmonologist is to provide excellent care for all children and adolescents with underlying lung disease. He sees all patients with pediatric lung diseases including but not limited to cystic fibrosis, chronic lung disease of prematurity, and asthma. The primary focus of his basic science is better understanding the mechanisms of rare lung diseases, such as childhood interstitial lung disease (chILD) and bronchiolitis obliterans (BO), in order to identify new medical therapies.

Professional Background

Inherent of Dr. McGraw's practice is providing thoughtful, evidence-based, family-centered care to all children and families. His primary goal is to promote the greatest developmentally appropriate growth and potential of all children, consistent with the mission of the University of Rochester's Department of Pediatrics. He works collaboratively with parents, primary and other care providers to achieve the best outcomes for children and adolescents with underlying lung disease.


Dr. McGraw's research involves understanding the mechanisms of aberrant airway epithelial repair after inhalation injuries. The primary pediatric lung disease studied is bronchiolitis obliterans (BO), a devastating and often progressive fibrotic lung disease characterized by progressive luminal narrowing and obliteration of the small airways, or bronchioles. Despite BO's high morbidity and mortality, very little is known about its pathogenesis, and even less is available in terms of prevention, intervention and treatment.

Inhalation agents used to study the mechanisms of aberrant airway epithelial repair include sulfur mustard (SM), a chemical warfare inhalation agent, and diacetyl, a volatile chemical in many flavorings. Both of these inhalation agents can cause bronchiolitis obliterans in children.

Basic science techniques include: small animal model development; primary airway epithelial cell isolation; flow sorting; 3D cell culture; single cell RNA sequencing.



  • Pediatrics - American Board of Pediatrics
  • Pediatric Pulmonology - American Board of Pediatrics


MD | Suny Upstate Medical University

Post-doctoral Training & Residency

07/01/2015 - 06/30/2018
Fellowship in Pediatric Pulmonology at University of Colorado Hospital- GME

07/01/2013 - 06/30/2015
Residency in Pediatrics at University of Virginia Children's Hospital

07/01/2012 - 06/30/2013
Internship in Pediatrics at University of Virginia Children's Hospital

VIEW ALL expand_more


2020 - 2022
KL2 Award
Sponsor: NCATS and URMC CTSI
Location: University of Rochester, Rochester, NY

2020 - 2021
Furth Award
Sponsor: Office of the Provost, University of Rochester
Location: Rochester, NY

2019 - 2021
NIH Loan Repayment Program
Sponsor: NIEHS
Location: University of Rochester, Rochester, NY

Best Research Poster, Junior Faculty
Sponsor: Department of Pediatrics, Golisano's Children's Hospital
Location: Rochester, NY

Society of Toxicology's Donald E. Gardner Inhalation Toxicology Education Award 2017

2016 - 2018
NIH T32 Training Grant, University of Colorado SOM, 2016 –2018

Mulholland Resident and Fellow Teaching Award, Honorable Mention, 2015

2014 - 2015
American Academy of Pediatrics, Resident CATCH Implementation Grant, 2014 – 2015

2014 - 2015
University of Virginia Pediatrics Resident Teaching Award, 2014 & 2015

2011 - 2012
Gold Humanism Honor Society

Bucknell University Department of Biomedical Engineering, Magna Cum Laude

2007 - 2008
Tau Beta Pi Engineering Honor Society

2005 - 2008
Bucknell University Dean's List

VIEW ALL expand_more


Journal Articles

McGraw MD, Croft DP, Nacca NE, Rahman I. "Reduced Plasma Phosphatidylethanolamines in E-cigarette, or Vaping, Product Use-Associated Lung Injury (EVALI)." Pediatric pulmonology.. 2022 Feb 28; Epub 2022 Feb 28.

House EL, Kim SY, Johnston CJ, Groves AM, Hernady E, Misra RS, McGraw MD. "Diacetyl Vapor Inhalation Induces Mixed, Granulocytic Lung Inflammation with Increased CD4CD25 T Cells in the Rat." Toxics.. 2021 Dec 20; 9(12)Epub 2021 Dec 20.

Clair G, Bramer LM, Misra R, McGraw MD, Bhattacharya S, Kitzmiller JA, Feng S, Danna VG, Bandyopadhyay G, Bhotika H, Huyck HL, Deutsch GH, Mariani TJ, Carson J, Whitsett JA, Pryhuber GS, Adkins JN, Ansong C. "Proteomic Analysis of Human Lung Development." American journal of respiratory and critical care medicine.. 2021 Nov 9; Epub 2021 Nov 09.